The Trust Layer for Market Analysts

On November 3rd, 2025, an analysis was conducted on Palantir Technologies (PLTR), advising investors against purchasing the stock. This recommendation was made despite the company demonstrating excellent business performance metrics, including accelerating revenue growth, expanding profit margins, increasing cash flow from operations to sales, and a premium return on invested capital. The core reasoning for the 'do not buy' stance was the stock's valuation, which was deemed too expensive when assessed using both a forward price-to-earnings ratio and a proprietary discounted cash flow (DCF) model. The DCF model specifically yielded an intrinsic share value of $79.02, significantly below the current market price of $165.49. Subsequent to this analysis, free cash flow expectations for Palantir were upgraded, and its risk profile was reportedly downgraded by adjusting its Beta coefficient to 0.8. This adjustment indicated a perception that the company was 80% as risky as in prior periods. Despite these positive internal adjustments and strong operational performance, the fundamental valuation consistently indicated overvaluation, leading to the reiterated 'do not buy' recommendation.